US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 16.775
  • -0.005-0.03%
Trading Feb 27 13:35 ET
19.22BMarket Cap-11.57P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
4.41%16.54B
-5.12%4.23B
12.49%4.33B
7.40%4.16B
4.29%3.82B
6.16%15.85B
14.78%4.46B
7.09%3.85B
2.43%3.88B
0.03%3.66B
Operating revenue
5.92%16.18B
-0.26%4.19B
13.29%4.23B
7.61%4.06B
3.67%3.7B
5.37%15.28B
9.85%4.21B
8.02%3.73B
2.50%3.77B
0.99%3.57B
Cost of revenue
3.43%8.48B
3.33%2.11B
9.20%2.18B
2.79%2.14B
-1.49%2.05B
3.12%8.2B
-3.41%2.04B
3.79%2B
4.52%2.08B
8.22%2.08B
Gross profit
5.48%8.06B
-12.17%2.12B
16.05%2.15B
12.69%2.02B
11.95%1.77B
9.64%7.65B
36.44%2.42B
10.90%1.85B
0.11%1.8B
-9.08%1.58B
Operating expense
5.59%4.7B
6.20%1.2B
6.11%1.16B
5.04%1.21B
5.12%1.13B
3.92%4.45B
-0.53%1.13B
10.25%1.1B
4.45%1.15B
1.99%1.07B
Selling and administrative expenses
5.83%3.7B
5.54%952M
9.48%924M
3.19%939M
5.23%886M
1.54%3.5B
7.77%902M
2.68%844M
0.33%910M
-4.32%842M
-Selling and marketing expense
8.78%2.54B
6.56%650M
8.68%626M
8.79%656M
11.36%608M
3.13%2.34B
11.11%610M
6.86%576M
1.52%603M
-6.51%546M
-General and administrative expense
-0.09%1.16B
3.42%302M
11.19%298M
-7.82%283M
-6.08%278M
-1.53%1.16B
1.39%292M
-5.30%268M
-1.92%307M
0.00%296M
Research and development costs
4.72%998M
8.81%247M
-5.14%240M
12.08%269M
3.42%242M
13.72%953M
8.10%227M
44.57%253M
5.26%240M
4.00%234M
Other operating expenses
----
----
----
----
150.00%1M
----
----
----
----
96.15%-2M
Operating profit
5.32%3.36B
-28.30%922M
30.50%984M
26.32%816M
26.38%642M
18.74%3.19B
102.52%1.29B
11.87%754M
-6.78%646M
-26.06%508M
Net non-operating interest income expense
4.11%-1.05B
0.00%-287M
2.86%-272M
10.07%-241M
3.85%-250M
-10.49%-1.1B
-6.30%-287M
-11.11%-280M
-27.01%-268M
-0.78%-260M
Non-operating interest expense
-2.62%1B
8.14%239M
-2.86%272M
-10.07%241M
-3.85%250M
10.65%1.03B
5.74%221M
11.11%280M
27.01%268M
0.78%260M
Total other finance cost
-27.27%48M
----
----
----
----
8.20%66M
----
----
----
----
Other net income (expense)
-32.10%-3.6B
-78.90%-882M
-152.57%-1.03B
36.77%-822M
-64.88%-859M
43.96%-2.72B
68.42%-493M
-60.39%-409M
20.88%-1.3B
62.79%-521M
Gain on sale of security
81.58%69M
----
----
----
----
46.15%38M
----
----
----
----
Special income (charges)
-33.78%-3.68B
-86.26%-922M
-153.13%-1.05B
37.84%-823M
-71.29%-877M
43.47%-2.75B
68.91%-495M
-63.78%-416M
19.02%-1.32B
62.87%-512M
-Less：Restructuring and merger&acquisition
-42.79%377M
-95.31%20M
1.85%55M
138.64%210M
1.10%92M
61.92%659M
124.21%426M
74.19%54M
-8.33%88M
1.11%91M
-Less:Impairment of capital assets
137.01%2.56B
1,072.06%797M
1,041.67%548M
-31.52%530M
261.17%679M
-55.95%1.08B
-95.29%68M
71.43%48M
-4.44%774M
13.94%188M
-Less:Other special charges
-26.78%760M
320.69%122M
43.31%450M
-82.03%83M
-54.51%106M
-49.83%1.04B
38.10%29M
61.03%314M
-36.63%462M
-79.27%233M
-Gain on sale of business
400.00%15M
----
----
----
----
-93.48%3M
----
----
----
----
-Gain on sale of property,plant,equipment
-92.00%2M
----
----
----
----
38.89%25M
----
----
----
----
Other non- operating income (expenses)
164.29%9M
19.44%-29M
185.71%20M
-95.83%1M
300.00%18M
46.15%-14M
-820.00%-36M
800.00%7M
400.00%24M
57.14%-9M
Income before tax
-105.77%-1.28B
-148.72%-247M
-606.25%-324M
73.35%-246M
-71.69%-467M
80.27%-624M
142.29%507M
-61.45%64M
20.43%-923M
71.99%-272M
Income tax
9,757.14%676M
-31.71%28M
675.00%69M
4,037.50%630M
-173.68%-52M
98.91%-7M
-72.48%41M
-111.21%-12M
98.22%-16M
-1,050.00%-19M
Earnings from equity interest net of tax
-50.00%1M
--0
--3M
100.00%2M
---4M
-90.48%2M
0.00%1M
----
--1M
----
Net income
-218.54%-1.96B
-158.89%-275M
-606.49%-390M
3.53%-874M
-65.61%-419M
75.39%-615M
134.67%467M
32.76%77M
-249.81%-906M
73.42%-253M
Net income continuous Operations
-218.54%-1.96B
-158.89%-275M
-613.16%-390M
3.53%-874M
-65.61%-419M
75.39%-615M
134.67%467M
31.03%76M
-248.46%-906M
73.42%-253M
Minority interest income
-471.43%-320M
-1,550.00%-58M
487.50%47M
17.14%-29M
-748.48%-280M
-5.66%-56M
112.50%4M
166.67%8M
-29.63%-35M
-1,200.00%-33M
Net income attributable to the parent company
-193.20%-1.64B
-146.87%-217M
-733.33%-437M
2.98%-846M
36.82%-139M
77.15%-559M
135.24%463M
23.21%69M
-275.86%-872M
76.96%-220M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-193.20%-1.64B
-146.87%-217M
-733.33%-437M
2.98%-846M
36.82%-139M
77.15%-559M
135.24%463M
23.21%69M
-275.86%-872M
76.96%-220M
Basic earnings per share
-190.00%-1.45
-146.34%-0.19
-750.00%-0.39
3.85%-0.75
40.00%-0.12
77.27%-0.5
137.27%0.41
20.00%0.06
-271.43%-0.78
76.74%-0.2
Diluted earnings per share
-190.00%-1.45
-146.34%-0.19
-750.00%-0.39
3.85%-0.75
40.00%-0.12
77.27%-0.5
137.27%0.41
20.00%0.06
-271.43%-0.78
76.74%-0.2
Dividend per share
0
0
0
0
0
0
0
0
0
0
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 4.41%16.54B-5.12%4.23B12.49%4.33B7.40%4.16B4.29%3.82B6.16%15.85B14.78%4.46B7.09%3.85B2.43%3.88B0.03%3.66B
Operating revenue 5.92%16.18B-0.26%4.19B13.29%4.23B7.61%4.06B3.67%3.7B5.37%15.28B9.85%4.21B8.02%3.73B2.50%3.77B0.99%3.57B
Cost of revenue 3.43%8.48B3.33%2.11B9.20%2.18B2.79%2.14B-1.49%2.05B3.12%8.2B-3.41%2.04B3.79%2B4.52%2.08B8.22%2.08B
Gross profit 5.48%8.06B-12.17%2.12B16.05%2.15B12.69%2.02B11.95%1.77B9.64%7.65B36.44%2.42B10.90%1.85B0.11%1.8B-9.08%1.58B
Operating expense 5.59%4.7B6.20%1.2B6.11%1.16B5.04%1.21B5.12%1.13B3.92%4.45B-0.53%1.13B10.25%1.1B4.45%1.15B1.99%1.07B
Selling and administrative expenses 5.83%3.7B5.54%952M9.48%924M3.19%939M5.23%886M1.54%3.5B7.77%902M2.68%844M0.33%910M-4.32%842M
-Selling and marketing expense 8.78%2.54B6.56%650M8.68%626M8.79%656M11.36%608M3.13%2.34B11.11%610M6.86%576M1.52%603M-6.51%546M
-General and administrative expense -0.09%1.16B3.42%302M11.19%298M-7.82%283M-6.08%278M-1.53%1.16B1.39%292M-5.30%268M-1.92%307M0.00%296M
Research and development costs 4.72%998M8.81%247M-5.14%240M12.08%269M3.42%242M13.72%953M8.10%227M44.57%253M5.26%240M4.00%234M
Other operating expenses ----------------150.00%1M----------------96.15%-2M
Operating profit 5.32%3.36B-28.30%922M30.50%984M26.32%816M26.38%642M18.74%3.19B102.52%1.29B11.87%754M-6.78%646M-26.06%508M
Net non-operating interest income expense 4.11%-1.05B0.00%-287M2.86%-272M10.07%-241M3.85%-250M-10.49%-1.1B-6.30%-287M-11.11%-280M-27.01%-268M-0.78%-260M
Non-operating interest expense -2.62%1B8.14%239M-2.86%272M-10.07%241M-3.85%250M10.65%1.03B5.74%221M11.11%280M27.01%268M0.78%260M
Total other finance cost -27.27%48M----------------8.20%66M----------------
Other net income (expense) -32.10%-3.6B-78.90%-882M-152.57%-1.03B36.77%-822M-64.88%-859M43.96%-2.72B68.42%-493M-60.39%-409M20.88%-1.3B62.79%-521M
Gain on sale of security 81.58%69M----------------46.15%38M----------------
Special income (charges) -33.78%-3.68B-86.26%-922M-153.13%-1.05B37.84%-823M-71.29%-877M43.47%-2.75B68.91%-495M-63.78%-416M19.02%-1.32B62.87%-512M
-Less：Restructuring and merger&acquisition -42.79%377M-95.31%20M1.85%55M138.64%210M1.10%92M61.92%659M124.21%426M74.19%54M-8.33%88M1.11%91M
-Less:Impairment of capital assets 137.01%2.56B1,072.06%797M1,041.67%548M-31.52%530M261.17%679M-55.95%1.08B-95.29%68M71.43%48M-4.44%774M13.94%188M
-Less:Other special charges -26.78%760M320.69%122M43.31%450M-82.03%83M-54.51%106M-49.83%1.04B38.10%29M61.03%314M-36.63%462M-79.27%233M
-Gain on sale of business 400.00%15M-----------------93.48%3M----------------
-Gain on sale of property,plant,equipment -92.00%2M----------------38.89%25M----------------
Other non- operating income (expenses) 164.29%9M19.44%-29M185.71%20M-95.83%1M300.00%18M46.15%-14M-820.00%-36M800.00%7M400.00%24M57.14%-9M
Income before tax -105.77%-1.28B-148.72%-247M-606.25%-324M73.35%-246M-71.69%-467M80.27%-624M142.29%507M-61.45%64M20.43%-923M71.99%-272M
Income tax 9,757.14%676M-31.71%28M675.00%69M4,037.50%630M-173.68%-52M98.91%-7M-72.48%41M-111.21%-12M98.22%-16M-1,050.00%-19M
Earnings from equity interest net of tax -50.00%1M--0--3M100.00%2M---4M-90.48%2M0.00%1M------1M----
Net income -218.54%-1.96B-158.89%-275M-606.49%-390M3.53%-874M-65.61%-419M75.39%-615M134.67%467M32.76%77M-249.81%-906M73.42%-253M
Net income continuous Operations -218.54%-1.96B-158.89%-275M-613.16%-390M3.53%-874M-65.61%-419M75.39%-615M134.67%467M31.03%76M-248.46%-906M73.42%-253M
Minority interest income -471.43%-320M-1,550.00%-58M487.50%47M17.14%-29M-748.48%-280M-5.66%-56M112.50%4M166.67%8M-29.63%-35M-1,200.00%-33M
Net income attributable to the parent company -193.20%-1.64B-146.87%-217M-733.33%-437M2.98%-846M36.82%-139M77.15%-559M135.24%463M23.21%69M-275.86%-872M76.96%-220M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -193.20%-1.64B-146.87%-217M-733.33%-437M2.98%-846M36.82%-139M77.15%-559M135.24%463M23.21%69M-275.86%-872M76.96%-220M
Basic earnings per share -190.00%-1.45-146.34%-0.19-750.00%-0.393.85%-0.7540.00%-0.1277.27%-0.5137.27%0.4120.00%0.06-271.43%-0.7876.74%-0.2
Diluted earnings per share -190.00%-1.45-146.34%-0.19-750.00%-0.393.85%-0.7540.00%-0.1277.27%-0.5137.27%0.4120.00%0.06-271.43%-0.7876.74%-0.2
Dividend per share 0000000000
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MARA Holdings
MARA
+11.45%
Coinbase
COIN
+1.30%
Apple
AAPL
+0.62%
Adobe
ADBE
+0.35%
Tesla
TSLA
+0.10%

Unlock the Full List

Investment Theme Infectious Disease
Infectious Disease
Intraday-0.14%